Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | CRNX | SMMT | ||
| Company | Arrowhead Pharma | Crinetics Pharmaceuticals Inc | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.63 | 42.49 | 3.88 | ||
| High | 21.63 | 42.87 | 3.88 | ||
| Low | 21.63 | 41.66 | 3.88 | ||
| Last | 21.63 | 42.12 | 3.88 | ||
| Change | -0.49 | -0.17 | +0.02 | ||
| % Change | -2.21% | -0.40% | +0.52% | ||
| Volume | 4,302 | 563,200 | 3,368 | ||
| 20-Day Average Volume | 845,635 | 787,730 | 1,540,208 | ||
| Previous Close | 22.12 | 42.29 | 3.86 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.20 | 44.94 | 3.74 | ||
| 20-Day Raw Stochastic | 3.98% | 12.54% | 64.29% | ||
| 20-Day Relative Strength | 33.99% | 47.14% | 50.81% | ||
| Weighted Alpha | -49.11 | +39.00 | +99.19 | ||
| Today's Opinion | 88% Sell | 56% Buy | 56% Buy | ||
| Previous Opinion | 88% Sell | 64% Buy | 56% Buy | ||
| Last Month's Opinion | 24% Sell | 100% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.57% since 04/22/24 | -1.98% since 04/19/24 | +11.17% since 04/22/24 | ||
| Low | 21.39 on 04/25/24 | 41.05 on 04/25/24 | 3.44 on 04/25/24 | ||
| High | 24.68 on 04/23/24 | 45.26 on 04/24/24 | 3.92 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -24.37% since 03/28/24 | -2.88% since 03/26/24 | -6.28% since 03/28/24 | ||
| Low | 21.39 on 04/25/24 | 41.05 on 04/25/24 | 3.34 on 04/19/24 | ||
| High | 28.50 on 04/01/24 | 49.58 on 04/04/24 | 4.24 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -37.12% since 01/29/24 | +13.29% since 01/26/24 | +2.92% since 01/29/24 | ||
| Low | 21.39 on 04/25/24 | 35.70 on 02/02/24 | 3.25 on 03/22/24 | ||
| High | 36.72 on 03/04/24 | 49.58 on 04/04/24 | 5.22 on 03/05/24 | ||
| 6-Month | |||||
| %Chg | -8.35% since 10/27/23 | +44.15% since 10/26/23 | +114.36% since 10/27/23 | ||
| Low | 20.67 on 12/01/23 | 25.75 on 11/10/23 | 1.64 on 11/09/23 | ||
| High | 39.83 on 01/10/24 | 49.58 on 04/04/24 | 5.22 on 03/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,740,602 | 2,931,552 | 2,708,574 | ||
| Shares Outstanding, K | 123,897 | 69,600 | 701,703 | ||
| Annual Sales | 240,740,000 | 4,010,000 | 0 | ||
| Annual Net Income | -205,280,000 | -214,530,000 | -614,930,000 | ||
| Last Quarter Sales | 3,550,000 | 350,000 | 0 | ||
| Last Quarter Net Income | -132,860,000 | -57,460,000 | -36,570,000 | ||
| 60-Month Beta | 0.71 | 0.63 | -1.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.24 on 02/06/24 | -0.90 on 02/28/24 | -0.04 on 02/20/24 | ||
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||